Golden Meditech and GE Healthcare Team Up to Develop Safe and Efficient Cord Blood Storage Services
HONG KONG, Nov. 16, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, today announces that it has formed a strategic collaboration with GE Healthcare. Pursuant to the collaboration, GE Healthcare will provide an integrated and automated digital system and solutions to the Group's umbilical cord blood cryopreservation processes, aiming to provide efficient storage services to customers at large.
Medical research in the past three decades have shown that umbilical cord blood contains rich hematopoietic stem cells. These stem cells could facilitate the reconstruction of hematopoietic and immune systems, and could also be applied to hematopoietic stem cell transplantation as well as the treatment of blood system, immune system and inherited metabolic diseases. Therefore, umbilical cord blood has become an important source of hematopoietic stem cells and is widely used clinically. Cord blood bank operation usually include cord blood collection and processing, laboratory testing, stem cell cryopreservation and storage. All these processes demanded high standard protocols. Through its partnership with GE Healthcare, the Group will utilise a fully automated cell processing system and associated disposable kit to meet the stringent requirements for extensive cord blood processing in an efficient and safe manner.
About Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market, the cord blood storage market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
About GE Healthcare
GE Healthcare, a subsidiary of GE (NYSE stock code: GE), provides innovative medical technologies and services that meet the needs of people across the world, offering them access to more affordable healthcare services. Focusing on multi-critical issues in the world, GE is committed to meeting the major industrial challenges using its talents and cutting-edge technologies. GE Healthcare assists healthcare professionals in delivering quality healthcare services to patients in a variety of fields, including medical imaging, software and information technology, patient monitoring and diagnosis, drug research and development, biopharmaceuticals and operational excellence solutions.
SOURCE Golden Meditech Holdings Limited
Upcoming Life Sciences Events
- February 2018
- Zurich: 11th Annual European Life Sciences CEO Forum & Exhibition
- March 2018
- : Phar-East 2018
- Cardiff: BioWales